Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder (Q38231743)

31 August 2017

title

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder (English)

1 reference

31 August 2017

Francois Haab

1

1 reference

31 August 2017

language of work or name

1 reference

1 July 2014

1 reference

Neurourology and Urodynamics

31 August 2017

published in

1 reference

31 August 2017

volume

33 Suppl 3

1 reference

31 August 2017

page(s)

S2-5

1 reference

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

31 August 2017

cites work

1 reference

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.

21 January 2018

1 reference

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

21 January 2018

1 reference

Utility scores for chronic conditions in a community-dwelling population

21 January 2018

1 reference

The economic impact of overactive bladder syndrome in six Western countries.

21 January 2018

1 reference

Overactive bladder: The importance of new guidance.

21 January 2018

1 reference

Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms

21 January 2018

1 reference

Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder

21 January 2018

1 reference

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder

21 January 2018

1 reference

Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit

21 January 2018

1 reference

Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men.

21 January 2018

1 reference

Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms.

21 January 2018

1 reference

Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder

21 January 2018

1 reference

Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry

21 January 2018

1 reference

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines

21 January 2018

1 reference

Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort

21 January 2018

1 reference

The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate.

21 January 2018

1 reference

The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK.

21 January 2018

1 reference

Can higher doses of oxybutynin improve efficacy in neurogenic bladder?

21 January 2018

1 reference

Epidemiology and healthcare utilization of neurogenic bladder patients in a us claims database

21 January 2018

1 reference

Anticholinergics for urinary symptoms in multiple sclerosis

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004193.PUB2

12 January 2024

Identifiers

DOI

10.1002/NAU.22636

1 reference

31 August 2017

1 reference